Alpine BioTherapeutics Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Out of Business

  • Latest Deal Type
  • Out of Business

Alpine BioTherapeutics General Information

Description

Developer of a next-generation stem cell-based therapy intended to bring a sense of light and hope back to patients. The company's therapy offer to preserve and restore eyesight in patients afflicted by dry age-related macular degeneration and retinitis pigmentosa, enabling patients to get treatment related to ocular damage from injuries and diseases.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • 10355 Science Center Drive
  • Suite 130
  • San Diego, CA 92121
  • United States
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 10355 Science Center Drive
  • Suite 130
  • San Diego, CA 92121
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Alpine BioTherapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Out of Business 26-May-2023 Completed Out of Business
2. Seed Round 10-May-2019 Completed Generating Revenue
1. Seed Round 26-May-2017 $500K $500K Completed Generating Revenue
To view Alpine BioTherapeutics’s complete valuation and funding history, request access »

Alpine BioTherapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Seed-1
Seed
To view Alpine BioTherapeutics’s complete cap table history, request access »

Alpine BioTherapeutics Patents

Alpine BioTherapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20240335562-A1 Sustainable ocular cell-mediated intraocular delivery of cellular therapeutics for treatment of ocular diseases or disorders Pending 04-Aug-2021

Alpine BioTherapeutics Acquisitions (1)

Alpine BioTherapeutics’s most recent deal was a Merger/Acquisition with Sightstream. The deal was made on 25-May-2022.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Sightstream 25-May-2022 Merger/Acquisition Drug Discovery
To view Alpine BioTherapeutics’s complete acquisitions history, request access »

Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
Sightstream Medfield, MA 2020

Alpine BioTherapeutics FAQs

  • When was Alpine BioTherapeutics founded?

    Alpine BioTherapeutics was founded in 2017.

  • Where is Alpine BioTherapeutics headquartered?

    Alpine BioTherapeutics is headquartered in San Diego, CA.

  • What industry is Alpine BioTherapeutics in?

    Alpine BioTherapeutics’s primary industry is Drug Discovery.

  • Is Alpine BioTherapeutics a private or public company?

    Alpine BioTherapeutics is a Private company.

  • What is Alpine BioTherapeutics’s current revenue?

    The current revenue for Alpine BioTherapeutics is .

  • How much funding has Alpine BioTherapeutics raised over time?

    Alpine BioTherapeutics has raised $1.8M.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »